Using both K562 cells and P815-ULBP1+CD48 cells as targets, the effector functions of CD3-CD56+ NK cells from patients with PC (malignant group) were compared with those of HCs (Tables S1–S4). This evidence concerns the gene NCAM1 and pachyonychia congenita.